The Rh antigen is a protein found on the surface of red blood cells. It’s the basis of the “positive” or “negative” label in your blood type. If you have the protein, you’re Rh-positive (like A+ or O+); if you lack it, you’re Rh-negative (like A- or O-). About 85% of people worldwide are Rh-positive, though the proportion varies significantly by ethnic background. The Rh system is the second most important blood group system after ABO, and it plays a major role in blood transfusions and pregnancy.
The Rh Protein and Where It Sits
When people say “the Rh antigen,” they usually mean the D antigen, the most clinically significant protein in the Rh blood group system. But the full system actually includes five main antigens: D, C, c, E, and e. Together, these five account for about 95% of all immune reactions linked to Rh antigens during transfusions and pregnancy.
The D antigen is carried by a protein called RhD, while the C, c, E, and e antigens sit on a closely related protein called RhCE. These two proteins are remarkably similar, differing in only 36 out of 417 amino acids. Both are embedded in the red blood cell membrane, threading through it 12 times. Unlike most proteins on cell surfaces, Rh proteins don’t have sugar chains attached to them. Instead, they work alongside a companion protein called RhAG, which is a glycoprotein.
The D antigen alone has over 30 distinct regions (called epitopes) that the immune system can recognize. This complexity is part of why Rh incompatibility can trigger such strong immune responses.
How Rh Type Is Inherited
Your Rh status comes down to two genes sitting close together on chromosome 1: the RHD gene and the RHCE gene. Whether you’re Rh-positive or Rh-negative depends on whether you have a functional copy of the RHD gene. Most Rh-negative people of European descent are missing the RHD gene entirely.
This deletion has deep evolutionary roots. Most mammals have only one Rh gene, equivalent to the human RHCE gene. The RHD gene arose from a duplication of that ancestral gene, and at some point during human evolution, a deletion occurred, meaning many modern humans completely lack it. You inherit one copy of each gene from each parent, so your Rh genotype can be homozygous (two copies of RHD), heterozygous (one copy), or null (no copies). Only the null combination makes you Rh-negative.
The difference between the C and c antigens, and between E and e, comes down to single amino acid changes in the RhCE protein. For example, if position 226 on the protein has the amino acid proline, you express the E antigen. If it has alanine instead, you express e.
Who Is Rh-Negative
Rh-negative blood is most common among people of European descent, where roughly 15% of the population lacks the D antigen. Among people of African descent, Rh-negative rates are lower, typically around 5 to 8%. In East Asian populations, the rate drops below 1%. In Singapore, for instance, only about 1.5% of blood donors are Rh-negative. Indian populations also have a notable proportion of Rh-negative individuals compared to other Asian groups.
Why Rh Matters in Pregnancy
The most well-known medical consequence of Rh status involves pregnancy. When an Rh-negative mother carries an Rh-positive baby (inheriting the D antigen from the father), the mother’s immune system can recognize the baby’s red blood cells as foreign. This process, called alloimmunization, typically happens when small amounts of fetal blood cross into the mother’s circulation, most commonly during delivery.
During a first pregnancy, the mother’s body produces a type of antibody (IgM) that is too large to cross the placenta, so the first baby is usually unaffected. The problem comes with subsequent pregnancies. The mother’s immune system now has memory of the D antigen, and upon encountering it again, it rapidly produces smaller antibodies (IgG) that can cross the placenta and attack the baby’s red blood cells.
This condition is called hemolytic disease of the fetus and newborn. In mild cases, the baby may develop jaundice and anemia shortly after birth. In severe cases, a condition called hydrops fetalis can develop, where fluid accumulates in the baby’s tissues and body cavities. Hydrops fetalis carries a mortality rate above 50%. If left untreated, the breakdown of red blood cells floods the baby’s system with bilirubin, which can accumulate in the brain and cause permanent neurological damage.
Fortunately, this is largely preventable. Rh-negative mothers receive an injection of Rh immune globulin (commonly known by the brand name RhoGAM) at around 26 to 28 weeks of pregnancy and again within 72 hours after delivering an Rh-positive baby. The injection contains antibodies that clear any fetal red blood cells from the mother’s system before her immune system can mount its own response. Additional doses are given after amniocentesis, miscarriage, or any event that might cause fetal blood to mix with maternal blood.
Rh Compatibility in Blood Transfusions
Rh status is one of the two critical factors (along with ABO type) checked before any blood transfusion. The core rule is straightforward: Rh-negative recipients should receive Rh-negative blood. Rh-positive recipients can safely receive either Rh-positive or Rh-negative blood. For example, someone with B+ blood can receive B+, B-, O+, or O- blood. Someone with B- can only receive B- or O-.
In emergencies where a patient’s blood type is unknown, O-negative blood is used because it carries neither A/B antigens nor the D antigen, making it compatible with virtually anyone. This is why O-negative donors are called “universal donors” and why blood banks are constantly working to maintain their O-negative supply.
If an Rh-negative person receives Rh-positive blood by mistake, their immune system may develop anti-D antibodies. A first exposure might not cause an obvious reaction, but any future transfusion with Rh-positive blood could trigger a hemolytic transfusion reaction, where the immune system destroys the transfused red blood cells.
What Rh Proteins Actually Do
For decades, scientists knew these proteins existed but had no idea what biological function they served. The answer turned out to be gas transport. Rh glycoproteins, particularly the related RhAG protein, help move ammonia across cell membranes. This function is especially important in the kidneys, where ammonia transport is central to maintaining the body’s acid-base balance.
Research has also shown that these proteins can transport carbon dioxide. Studies using human red blood cells that lack RhAG found that CO2 transport was measurably reduced. All three mammalian Rh glycoproteins (found in red blood cells, kidneys, and liver) have been shown to transport CO2 in laboratory experiments. So while the Rh system is best known for its role in blood typing, the underlying proteins serve a basic physiological function in moving gas molecules across cell membranes.